Zelira Therapeutics Ltd: HOPE SPV receives US$681,000 third tranche of funding
Zelira Therapeutics Ltd: Appendix 4C Cash Flow Report
Zelira Therapeutics Ltd: March 2024 Quarterly Activities Report
Zelira Therapeutics Ltd: Zelira receives $919,000 R&D Tax Incentive Scheme Refund
Zelira Therapeutics Ltd: Appendix 4D & FY24 Interim Financial Report
Zelira Therapeutics Ltd: Appendix 4C Cash Flow Report
Zelira Therapeutics Ltd: December 2023 Quarterly Activities Report
Zelira Therapeutics Ltd: Notification regarding unquoted securities - ZLD
Zelira Therapeutics Ltd: Notification of cessation of securities - ZLD
Zelira Therapeutics Ltd: Change of Auditor
Zelira Therapeutics Ltd: HOPE SPV receives US$819,000 second tranche of funding
Zelira Therapeutics Ltd: Change of Director's Interest Notice x 5
Zelira Therapeutics Ltd: Notification regarding unquoted securities - ZLD
Zelira Therapeutics Ltd: Proposed issue of securities - ZLD
Zelira Therapeutics Ltd: Results of Meeting
Zelira Therapeutics Ltd: 2023 Annual General Meeting Presentation
Zelira Therapeutics Ltd: Notification of cessation of securities - ZLD
Zelira Therapeutics Ltd: Notification of cessation of securities - ZLD
Zelira Therapeutics Ltd: Appendix 4C Cash Flow Report
Zelira Therapeutics Ltd: September 2023 Quarterly Activities Report
No Data